APA (7th ed.) Citation

Zhang, Y., Xu, M., Wang, Y., Yu, F., Chen, X., Wang, G., . . . Su, X. (2025). Value of [18F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging, 52(6), 2118-2131. https://doi.org/10.1007/s00259-025-07084-7

Chicago Style (17th ed.) Citation

Zhang, Yafei, Mimi Xu, Yu Wang, Fang Yu, Xinxin Chen, Guangfa Wang, Kui Zhao, Hong Yang, and Xinhui Su. "Value of [18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathological Response and Survival in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy." European Journal of Nuclear Medicine and Molecular Imaging 52, no. 6 (2025): 2118-2131. https://doi.org/10.1007/s00259-025-07084-7.

MLA (9th ed.) Citation

Zhang, Yafei, et al. "Value of [18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathological Response and Survival in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy." European Journal of Nuclear Medicine and Molecular Imaging, vol. 52, no. 6, 2025, pp. 2118-2131, https://doi.org/10.1007/s00259-025-07084-7.